Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 16351-16400 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05074537
The Wright Center of Innovation Imaging Archive
N/AActive, not recruiting
10,000 participants
Started: Jan 1, 2019 · Completed: May 31, 2030
1 condition1 sponsor1 location
NCT03957707
Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation
NAActive, not recruiting
380 participants
Started: Jan 1, 2019 · Completed: Oct 31, 2025
1 condition14 sponsors1 location
NCT03776799
BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery
NAActive, not recruiting
120 participants
Started: Jan 1, 2019 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT03841279
Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis
N/AActive, not recruiting
100 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07074535
CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer
N/AActive, not recruiting
500 participants
Started: Jan 1, 2019 · Completed: Dec 30, 2027
4 conditions1 sponsor1 location
NCT04205513
Use of Telemonitoring to Facilitate Heart Failure Medication Titration
NAActive, not recruiting
108 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03716349
Esthetics of Dental Composite and Adhesive System
NAActive, not recruiting
37 participants
Started: Jan 1, 2019 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT03621644
Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer
NAActive, not recruiting
133 participants
Started: Jan 1, 2019 · Completed: Jan 31, 2027
1 condition1 sponsor13 locations
NCT04772625
Failure Analysis of Patellofemoral Arthroplasty
N/AActive, not recruiting
550 participants
Started: Jan 1, 2019 · Completed: Apr 1, 2026
3 conditions2 sponsors1 location
NCT03794375
Primary Care Transfer for Thyroid Cancer Patients
NAActive, not recruiting
206 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06235164
The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer
N/AActive, not recruiting
585 participants
Started: Jan 1, 2019 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03753997
A Trial of Diabetes-educated Psychologist to Improve HbA1c and Reduce Diabetes-related Distress
NAActive, not recruiting
142 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06150495
Glycemic Control and Retinal Microvascular Changes
N/AActive, not recruiting
259 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04788602
The Applications and Influences of Transthoracic Echocardiography in Stroke Patients
N/AActive, not recruiting
2,000 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03793140
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
PHASE2Active, not recruiting
24 participants
Started: Dec 31, 2018 · Completed: Dec 31, 2025
2 conditions5 sponsors11 locations
NCT03737734
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
NAActive, not recruiting
30 participants
Started: Dec 31, 2018 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT03728361
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
PHASE2Active, not recruiting
55 participants
Started: Dec 31, 2018 · Completed: Oct 31, 2026
12 conditions2 sponsors2 locations
NCT03834792
Adverse Long-term Consequences of Sleep Disordered Breathing: The Ottawa Hospital (TOH) Sleep Database
N/AActive, not recruiting
5,155 participants
Started: Dec 30, 2018 · Completed: Dec 31, 2028
8 conditions4 sponsors1 location
NCT03722420
Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
PHASE3Active, not recruiting
238 participants
Started: Dec 28, 2018 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT03695601
Surveillance HeartCare® Outcomes Registry
N/AActive, not recruiting
2,743 participants
Started: Dec 28, 2018 · Completed: Nov 30, 2026
1 condition1 sponsor67 locations
NCT03616886
Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC
PHASE1/PHASE2Active, not recruiting
129 participants
Started: Dec 28, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors16 locations
NCT03650114
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
PHASE3Active, not recruiting
1,882 participants
Started: Dec 28, 2018 · Completed: Sep 30, 2028
1 condition1 sponsor296 locations
NCT03717909
Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome
PHASE2Active, not recruiting
63 participants
Started: Dec 28, 2018 · Completed: Nov 15, 2024
1 condition1 sponsor6 locations
NCT03819465
A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
PHASE1Active, not recruiting
175 participants
Started: Dec 27, 2018 · Completed: Mar 26, 2026
1 condition1 sponsor41 locations
NCT03944434
FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer
PHASE2Active, not recruiting
116 participants
Started: Dec 27, 2018 · Completed: Nov 27, 2025
1 condition2 sponsors1 location
NCT03734029
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
PHASE3Active, not recruiting
557 participants
Started: Dec 27, 2018 · Completed: Aug 1, 2026
1 condition3 sponsors208 locations
NCT03725059
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
PHASE3Active, not recruiting
1,240 participants
Started: Dec 27, 2018 · Completed: Jan 24, 2031
1 condition1 sponsor244 locations
NCT03840239
TNT to Increase the Clinical Complete Response Rate for Distal LARC
PHASE2Active, not recruiting
98 participants
Started: Dec 25, 2018 · Completed: Jun 30, 2027
4 conditions1 sponsor1 location
NCT03559049
Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
25 participants
Started: Dec 24, 2018 · Completed: Jun 30, 2028
1 condition3 sponsors3 locations
NCT03711032
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
PHASE3Active, not recruiting
1,397 participants
Started: Dec 24, 2018 · Completed: Nov 20, 2034
1 condition1 sponsor206 locations
NCT03958136
Clinico-biological Data Collection Study of Metastatic Breast Cancer
NAActive, not recruiting
289 participants
Started: Dec 24, 2018 · Completed: Dec 30, 2036
1 condition5 sponsors2 locations
NCT03717584
A Cohort Study of the Intestinal Microbiota of Premature Infants
N/AActive, not recruiting
300 participants
Started: Dec 23, 2018 · Completed: Mar 5, 2027
3 conditions1 sponsor1 location
NCT03631043
Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
EARLY_PHASE1Active, not recruiting
30 participants
Started: Dec 21, 2018 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT03101891
Renal Anhydramnios Fetal Therapy
PHASE1Active, not recruiting
70 participants
Started: Dec 21, 2018 · Completed: Feb 28, 2030
7 conditions2 sponsors9 locations
NCT03631199
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects
PHASE3Active, not recruiting
673 participants
Started: Dec 21, 2018 · Completed: Jun 7, 2027
1 condition1 sponsor153 locations
NCT04085276
Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment
PHASE3Active, not recruiting
531 participants
Started: Dec 21, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor53 locations
NCT03836352
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
PHASE2Active, not recruiting
184 participants
Started: Dec 21, 2018 · Completed: Dec 31, 2023
5 conditions2 sponsors23 locations
NCT03038672
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
PHASE2Active, not recruiting
54 participants
Started: Dec 21, 2018 · Completed: Oct 25, 2025
35 conditions1 sponsor33 locations
NCT03775486
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
PHASE2Active, not recruiting
401 participants
Started: Dec 21, 2018 · Completed: Sep 27, 2026
1 condition1 sponsor69 locations
NCT03765450
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
N/AActive, not recruiting
18 participants
Started: Dec 21, 2018 · Completed: Mar 2, 2026
1 condition1 sponsor3 locations
NCT03742102
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
PHASE1/PHASE2Active, not recruiting
243 participants
Started: Dec 21, 2018 · Completed: Feb 26, 2027
1 condition1 sponsor32 locations
NCT03659981
Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study
NAActive, not recruiting
32 participants
Started: Dec 20, 2018 · Completed: Nov 19, 2026
1 condition1 sponsor1 location
NCT03810404
Acute Sodium Bicarbonate Supplementation in Athletes
PHASE3Active, not recruiting
50 participants
Started: Dec 20, 2018 · Completed: Jan 20, 2025
2 conditions1 sponsor1 location
NCT03794635
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer
NAActive, not recruiting
45 participants
Started: Dec 20, 2018 · Completed: Dec 31, 2025
6 conditions2 sponsors1 location
NCT03681028
Feasibility of Individualized Therapy for Recurrent Glioblastoma
PHASE1Active, not recruiting
30 participants
Started: Dec 19, 2018 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05498896
Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC
PHASE2Active, not recruiting
146 participants
Started: Dec 19, 2018 · Completed: Jan 30, 2026
1 condition4 sponsors1 location
NCT03734198
Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia with P53 Dysfunction
PHASE2Active, not recruiting
29 participants
Started: Dec 19, 2018 · Completed: Dec 19, 2025
1 condition2 sponsors24 locations
NCT03675256
The KEN SHE Study on HPV-vaccine Efficacy
PHASE4Active, not recruiting
2,275 participants
Started: Dec 19, 2018 · Completed: Feb 15, 2024
1 condition3 sponsors3 locations
NCT03720704
Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels
N/AActive, not recruiting
280 participants
Started: Dec 18, 2018 · Completed: Jul 31, 2027
1 condition1 sponsor11 locations
NCT03818880
Choroidal Response to Novel Spectacle Lens to Control Myopia Progression
NAActive, not recruiting
10 participants
Started: Dec 18, 2018 · Completed: Mar 31, 2026
1 condition2 sponsors1 location